...
首页> 外文期刊>Cardiology >Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis.
【24h】

Functional capacity impairment in patients with coronary artery disease: prevalence, risk factors and prognosis.

机译:冠心病患者的功能能力受损:患病率,危险因素和预后。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Some patients developing heart failure and functional capacity impairment have no history of myocardial infarction (MI), and stable angina pectoris is their principal clinical manifestation of coronary artery disease (CAD). The present study was aimed to evaluate the outcome of CAD-related functional capacity impairment in patients with and without a history of MI over a 7.7-year follow-up. METHODS: The study sample comprised 14,283 coronary patients aged 45-74 years, screened for participation in the Bezafibrate Infarction Prevention study. The presence of NYHA functional class II was defined as mild functional capacity impairment and the presence of NYHA functional class III-IV was defined as advanced functional capacity impairment. RESULTS: The patients were divided in two groups: (1) those with a history of MI, 10,307 patients, who formed three subgroups: NYHA I 7,551 patients (73.3%); NYHA II 2,176 patients (21.1%); NYHA III + IV 580 patients (5.6%), and (2) those without a history of MI, 3,976 patients, who also formed three subgroups: NYHA I 2,744 patients (69.0%); NYHA 981 patients (24.7%); NYHA III + IV 251 patients (6.3%). Multivariate analysis identified a history of MI as a consistent predictor of increased all-cause and cardiac mortality for patients with NYHA I, II and III + IV subgroups with escalating significance for patients with advanced functional capacity impairment: hazard ratios of 1.55 (95% CI 1.36-1.75), 1.56 (95% CI 1.30-1.86) and 1.72 (95% CI 1.24-2.40) for all-cause and 1.93 (95% CI 1.60-2.33), 1.73 (95% 1.35-2.20) and 3.22 (95% CI 1.87-5.54) for cardiac mortality, respectively. CONCLUSIONS: The prevalence of low functional capacity is similar among coronary patients with and without a history of MI, but their long-term survival differs substantially in favor of the latter. Therefore, two different types of CAD-related advanced functional capacity impairments (post-MI and non-post-MI) can be distinguished.
机译:背景:一些发展为心力衰竭和功能障碍的患者没有心肌梗塞(MI)病史,稳定的心绞痛是他们冠状动脉疾病(CAD)的主要临床表现。本研究旨在评估在7.7年的随访中有无MI病史的患者的CAD相关功能能力受损的结果。方法:该研究样本包括14283例年龄在45-74岁之间的冠心病患者,这些患者经过筛查是否参与了贝扎贝特预防梗死研究。 NYHA功能性II类的存在被定义为轻度功能性功能障碍,而NYHA功能性III-IV类的存在被定义为高级功能性功能障碍。结果:患者分为两组:(1)有MI史的患者10307例,分为三个亚组:NYHA I 7551例(73.3%); NYHA II 2,176名患者(21.1%); NYHA III + IV 580例患者(5.6%),以及(2)无心梗史的3976例患者,他们也分为三个亚组:NYHA I 2744例(69.0%); NYHA 981例(24.7%); NYHA III + IV 251例患者(6.3%)。多变量分析确定MI的病史是NYHA I,II和III + IV亚组患者全因和心脏死亡率增加的一致预测指标,对晚期功能障碍患者的危险性逐步升高:危险比为1.55(95%CI 1.3-6.75),1.56(95%CI 1.30-1.86)和1.72(95%CI 1.24-2.40)和1.93(95%CI 1.60-2.33),1.73(95%1.35-2.20)和3.22( 95%CI为1.87-5.54)。结论:有或没有MI史的冠心病患者低功能能力的患病率相似,但他们的长期生存率存在显着差异,而后者则更为有利。因此,可以区分两种与CAD相关的高级功能能力受损(MI后和非MI后)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号